Nukkleus Valuation
| NUKKW Stock | 0.03 0.00 0.00% |
Nukkleus seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Nukkleus from analyzing the firm fundamentals such as Current Valuation of 330.32 M, return on equity of -0.75, and Profit Margin of (2.53) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Nukkleus' valuation include:
Enterprise Value 330.3 M | Enterprise Value Ebitda (46.02) | Price Sales 347.2509 | Enterprise Value Revenue 14.7689 |
Overvalued
Today
Please note that Nukkleus' price fluctuation is out of control at this time. Calculation of the real value of Nukkleus is based on 3 months time horizon. Increasing Nukkleus' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Nukkleus stock is determined by what a typical buyer is willing to pay for full or partial control of Nukkleus. Since Nukkleus is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nukkleus Stock. However, Nukkleus' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0301 | Real 0.19 | Hype 0.25 | Naive 0.0453 |
The intrinsic value of Nukkleus' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Nukkleus' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Nukkleus helps investors to forecast how Nukkleus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nukkleus more accurately as focusing exclusively on Nukkleus' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Nukkleus' intrinsic value based on its ongoing forecasts of Nukkleus' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Nukkleus' closest peers.
Nukkleus Cash |
|
Nukkleus Valuation Trend
Analysing the historical paterns of Nukkleus' enterprise value and its market capitalization is a good way to estimate and gauge the value of Nukkleus over time and is usually enough for investors to make rational market timing decisions.
Nukkleus Total Value Analysis
Nukkleus is now forecasted to have takeover price of 330.32 M with market capitalization of 3.73 B, debt of 3.65 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Nukkleus fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
330.32 M | 3.73 B | 3.65 M |
Nukkleus Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Nukkleus has an asset utilization ratio of 88.33 percent. This indicates that the Company is making USD0.88 for each dollar of assets. An increasing asset utilization means that Nukkleus is more efficient with each dollar of assets it utilizes for everyday operations.Nukkleus Profitability Analysis
The company reported the revenue of 16.22 M. Net Loss for the year was (11.85 M) with profit before overhead, payroll, taxes, and interest of 0.About Nukkleus Valuation
Our relative valuation model uses a comparative analysis of Nukkleus. We calculate exposure to Nukkleus's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Nukkleus's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -58.4 K | -55.5 K | |
| Pretax Profit Margin | (0.18) | (0.19) | |
| Operating Profit Margin | (0.18) | (0.19) | |
| Net Loss | (0.18) | (0.19) |
Nukkleus Growth Indicators
Investing in growth stocks can be very risky. If the company such as Nukkleus does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 10.1 M |
Nukkleus Current Valuation Indicators
Valuation refers to the process of determining the present value of Nukkleus and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Nukkleus we look at many different elements of the entity such as Nukkleus's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Nukkleus, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Nukkleus' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Nukkleus' worth.Additional Tools for Nukkleus Stock Analysis
When running Nukkleus' price analysis, check to measure Nukkleus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nukkleus is operating at the current time. Most of Nukkleus' value examination focuses on studying past and present price action to predict the probability of Nukkleus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nukkleus' price. Additionally, you may evaluate how the addition of Nukkleus to your portfolios can decrease your overall portfolio volatility.